0.8200SEK+2.50%Mkt Cap: 25.14M $P/E: —Today
Isofol Medical AB (publ) operates as a clinical stage biotech company. It develops arfolitixorin, which is in phase Ib/II clinical trial for the treatment of metastatic colorectal cancer. The company was incorporated in …
Industry Peers
Biotechnology$130.23BUSDP/E 32.1
$139.84BUSDP/E 32.2
$85.11BUSDP/E 20.4
$69.62BUSD
$61.34BUSDP/E 39.8
$45.95BUSDP/E 19.6
$46.01BUSD
$41.76BUSDP/E 66.2
$35.67BUSDP/E 33.2
$32.46BUSDP/E 42.3
$28.53BUSD
$26.14BUSD
$25.79BUSDP/E 16.2
$20.83BUSDP/E 26.3
$19.26BUSDP/E 26.6
$17.03BUSDP/E 20.0
$16.41BUSD
$13.48BUSDP/E 17.1
$13.42BUSDP/E 187.4
$12.87BUSDP/E 264.5
Key Statistics
Company
Market Cap25.14M $
Enterprise Value10.92M $
Revenue (TTM)—
Gross Profit-3.84M $
Net Income (TTM)-5.18M $
Revenue/Share—
Last Price0.8200 SEK
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees6
CountrySE
SectorHealthcare
IndustryBiotechnology
ISINSE0009581051
Valuation
P/E (Trailing)—
P/E (Forward)-16.32
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B2.47
EPS (TTM)-0.22
EPS (Forward)-0.05
52W Range
0.551561% of range0.9900
52W High0.9900 SEK
52W Low0.5515 SEK
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-50.22%
ROA-41.86%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-4.97M $
CapEx (TTM)—
FCF Margin—
FCF Yield-13.67%
Net Debt-10.59M $
Net Debt/EBITDA—
Balance Sheet
Debt/Equity—
Current Ratio5.57
Quick Ratio5.50
Book Value/Sh0.3300 SEK
Cash/Share0.3940 SEK
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 SEK
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)3.600 SEK
Upside (mean)+339.0%
Target Range1.900 SEK – 5.300 SEK
SEK1.900+339.0% to meanSEK5.300
# Analysts2
Ownership
Shares Out.320.49M
Float200.11M
Insiders26.07%
Institutions14.98%
Technical
SMA 500.7731 (+6.1%)
SMA 2000.7124 (+15.1%)
Beta1.03
S&P 52W Chg18.16%
Avg Vol (30d)435.58K
Avg Vol (10d)354.35K
Technical Indicators
RSI (14)48.7
MACD0.0170
MACD Signal0.0215
MACD Hist.-0.0045
BB Upper0.9042 SEK
BB Middle0.8146 SEK
BB Lower0.7250 SEK
BB Width22.01%
ATR (14)0.0551 SEK
Vol Ratio (20d)1.08x